Evidence map›Paper›PMID 37434182›Full record

ArticleGenome biology2023

CMOT: Cross-Modality Optimal Transport for multimodal inference.

Sayali Anil Alatkar, Daifeng Wang

Abstract read
In one paragraph

Article in Genome biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sayali Anil AlatkarWaisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Daifeng WangWaisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA. daifeng.wang@wisc.edu.ORCID 0000-0001-9190-3704

Funding

Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer DiseaseR01AG067025 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FINKBEINER, STEVEN M, HAROUTUNIAN, VAHRAM · 2019 to 2023
$11.8M
Waisman Center Intellectual and Developmental Disabilities Research CenterP50HD105353 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI Qiang Chang · 2021 to 2026
$8.5M
Creation of a Schwann Cell Gene Regulatory NetworkR21NS127432 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI SVAREN, JOHN P, WANG, DAIFENG · 2022 to 2023
$401k
Prediction and Validation of Oligodendrocyte Gene Regulatory Network from Multi-OmicsR21NS128761 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI SVAREN, JOHN P, WANG, DAIFENG · 2022 to 2022
$401k
NIA NIH HHS R01 AG067025NICHD NIH HHS P50 HD105353NINDS NIH HHS R21 NS127432NINDS NIH HHS R21 NS128761
6 · The paper itself

Abstract

Multimodal measurements of single-cell sequencing technologies facilitate a comprehensive understanding of specific cellular and molecular mechanisms. However, simultaneous profiling of multiple modalities of single cells is challenging, and data integration remains elusive due to missing modalities and cell-cell correspondences. To address this, we developed a computational approach, Cross-Modality Optimal Transport (CMOT), which aligns cells within available multi-modal data (source) onto a common latent space and infers missing modalities for cells from another modality (target) of mapped source cells. CMOT outperforms existing methods in various applications from developing brain, cancers to immunology, and provides biological interpretations improving cell-type or cancer classifications.

Indexed as

Single-Cell AnalysisCross-modal inferenceMultimodal data alignmentOptimal transportProbabilistic couplingSingle-cell multi-modalityWeighted nearest neighbor

Identifiers

PMID37434182
PMCPMC10334579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.